Drawing for MODAS

USPTO serial 75190773

MODAS

Reviewed by CopyMark Law Group

Reg. 2194655Status 710
Filing date
Status date
Registration date
Oct 13, 1998
Examiner
POWERS, ALEXANDER L
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with MODAS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

MARLA J CHURCH

MARLA J CHURCH ELAN PHARMACEUTICAL RESEARCH CORP1300 GOULD DRGAINESVILLE, GA 30504UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005non-disintegrating tablet formulations designed to control the absorption of highly water soluble drugs sold as an integral component of various oral pharmaceuticals in the nature of antacids, antispasmodics and anti-ulcerants, laxatives, anti-diarrhoeals, colorectal agents, cardiac drugs, drugs for the treatment of disorders of the central nervous system, CNS stimulants, analgesics, antipyretics and anti-inflammatory agents, muscle relaxants, hormonal, enzymal and steroidal preparations, drugs affecting bone metabolism, drugs affecting the genito-urinary system, diuretics and anti-diuretics, anti-infectives, anti-virals and immunological agents, electrolytes, vitamins and anabolic agents, bronchodilators, anti-asthmatics, expectorants, anti-tussives, decongestants, mucolytics and respiratory stimulants, oropharyngeal, aural and ocular preparations, anti-allergic drugs, hypo-sensitizing preparations, local and general anesthetics, oral and transdermal contraceptives, pharmaceutical preparations for the treatment of dermatological disorders, antineoplastic pharmaceutical preparations for inhibiting or preventing the growth and spread of neoplasms or malignant cells, and medical diagnostic reagents for administration in humansSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 16, 2005C8..CANCELLED SEC. 8 (6-YR)—
Oct 13, 1998R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 21, 1998PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 19, 1998NPUBNOTICE OF PUBLICATION—
Apr 21, 1998CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 13, 1998CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 9, 1997CNEAEXAMINER'S AMENDMENT MAILED—
Aug 1, 1997CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 29, 1997CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 16, 1997DOCKASSIGNED TO EXAMINER—
May 15, 1997DOCKASSIGNED TO EXAMINER—
May 13, 1997DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance